GGrantIndex
← Leaderboards

Prashant Mahajan

Wayne State University

$7,868,609
Attributed
$20,884,978
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY200925
$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,765,427 · 5
AHRQ$4,119,551 · 3

By mechanism

R01$13,113,490 · 4
U01$4,350,648 · 1
R18$2,476,656 · 1
RC1$894,493 · 1
R13$49,691 · 1

Most similar at Wayne State University

Same institution · by research overlap

Others in their field

Top investigators on “Hour

Research focus

HourMultidisciplinaryDiagnosisAccident And Emergency DepartmentDiagnosticChildhoodEnrollmentSamplingEvaluationChildCostAntibioticsGuidelinesInfectionResearch PersonnelTechnologyLaboratoriesBloodInflammatoryPublic Health RelevanceHospitalizationBacterial InfectionsBody FluidsBlood Specimen

Grant awards (30)

High performance wearable body odor sensor arrays for disease detection and monitoring$1,192,517
U01 · FY2025 · TR
Resubmission: Elucidating Pediatric Sepsis by Defining Comprehensive Signatures for Diagnosis and Outcome$578,886
R01 · FY2025 · HD · contact PI
High performance wearable body odor sensor arrays for disease detection and monitoring$1,203,721
U01 · FY2024 · TR
Resubmission: Elucidating Pediatric Sepsis by Defining Comprehensive Signatures for Diagnosis and Outcome$590,077
R01 · FY2024 · HD · contact PI
High performance wearable body odor sensor arrays for disease detection and monitoring$1,008,334
U01 · FY2023 · TR
Resubmission: Elucidating Pediatric Sepsis by Defining Comprehensive Signatures for Diagnosis and Outcome$586,187
R01 · FY2023 · HD · contact PI
High performance wearable body odor sensor arrays for disease detection and monitoring$946,076
U01 · FY2022 · TR
Resubmission: Elucidating Pediatric Sepsis by Defining Comprehensive Signatures for Diagnosis and Outcome$595,488
R01 · FY2022 · HD · contact PI
Improving Diagnosis in Emergency and Acute Care: A Learning Laboratory (IDEA-LL)$621,415
R18 · FY2021 · HS · contact PI
Developing a Framework to Study and Improve Communication to Enhance Diagnostic Quality in the ED$49,691
R13 · FY2021 · HS · contact PI
Improving Diagnosis in Emergency and Acute Care: A Learning Laboratory (IDEA-LL)$621,414
R18 · FY2020 · HS · contact PI
Missed Opportunities for Improving Diagnosis in Pediatric Emergency Care$305,673
R01 · FY2020 · HS · contact PI
RNA Biosignatures: A Paradigm Change for the Management of Young Febrile Infants$958,021
R01 · FY2019 · HD · contact PI
Improving Diagnosis in Emergency and Acute Care: A Learning Laboratory (IDEA-LL)$621,415
R18 · FY2019 · HS · contact PI
Missed Opportunities for Improving Diagnosis in Pediatric Emergency Care$320,886
R01 · FY2019 · HS · contact PI
RNA Biosignatures: A Paradigm Change for the Management of Young Febrile Infants$1,140,513
R01 · FY2018 · HD · contact PI
Improving Diagnosis in Emergency and Acute Care: A Learning Laboratory (IDEA-LL)$612,412
R18 · FY2018 · HS · contact PI
Missed Opportunities for Improving Diagnosis in Pediatric Emergency Care$319,815
R01 · FY2018 · HS · contact PI
RNA Biosignatures: A Paradigm Change for the Management of Young Febrile Infants$1,364,123
R01 · FY2017 · HD · contact PI
Missed Opportunities for Improving Diagnosis in Pediatric Emergency Care$320,926
R01 · FY2017 · HS · contact PI
RNA Biosignatures: A Paradigm Change for the Management of Young Febrile Infants$1,128,934
R01 · FY2016 · HD · contact PI
Missed Opportunities for Improving Diagnosis in Pediatric Emergency Care$325,904
R01 · FY2016 · HS · contact PI
RNA Biosignatures: A Paradigm Change for the Management of Young Febrile Infants$1,423,234
R01 · FY2015 · HD · contact PI
RNA Biosignatures in the Emergency Evaluation of Febrile Infants$553,848
R01 · FY2014 · HD · contact PI
RNA Biosignatures in the Emergency Evaluation of Febrile Infants$545,914
R01 · FY2013 · HD · contact PI
RNA Biosignatures in the Emergency Evaluation of Febrile Infants$584,677
R01 · FY2012 · HD · contact PI
RNA Biosignatures in the Emergency Evaluation of Febrile Infants$643,595
R01 · FY2011 · HD · contact PI
RNA Biosignatures in the Emergency Evaluation of Febrile Infants$826,789
R01 · FY2010 · HD · contact PI
Comparison of the Effectiveness of CAM Therapies in Pediatric Patients Undergoing$453,033
RC1 · FY2010 · AT
Comparison of the Effectiveness of CAM Therapies in Pediatric Patients Undergoing$441,460
RC1 · FY2009 · AT